Plan a Healthy Baby and Avoid the Chances of Genetic Disorders With Igenomix

Tuesday, February 21, 2017 Genetics & Stem Cells News
Email Print This Page Comment bookmark
Font : A-A+

NEW DELHI, February 21, 2017 /PRNewswire/ --

10 in 1000 Live Births Suffer From Genetic Disorders 


run in the family. No parent in this world would like to see their child affected by disorders which are severe and not curable.

Usually parents do not pay much attention to genetic disorders. This lack of awareness and ignorance has caused many

children to be born with genetic disorders such as Thalassemia, Haemophilia, Cystic fibrosis, etc. It can come as a shock to the parents because they are mostly unaware that they were carriers of genetic disorders and leave them with a lifelong guilt. Carriers of the recessive genetic disorder are healthy people, so it often goes out of notice that they can be passing genetic disorders to their children. "If you know that you are a carrier of a recessive genetic disorder, you can prevent the risk of having your children affected with the disorder. It is therefore important that you get yourself screened before planning your family to find out if you are a carrier or not. In fact, if both the parents are carriers of recessive disorders, then the risk of having children affected with that disorder is 25%," adds Dr. Rajni Khajuria from Igenomix.

Igenomix has developed an advanced Carrier Genetic Test (CGT) that identifies if the patient is a carrier or not; thereby highlighting the risk they have for having children affected with that disease. If identified in advance, steps can be taken to ensure a healthy pregnancy. CGT is an important genetic test for family planning which determines the risk of having a child with genetic disorder. The test needs to be conducted on the parents. If the parents are identified as high risk for a particular disease, then they have options such as Preimplantation Genetic Diagnosis (PGD) or Gamete donation which can help in conceiving a healthy child. "Out of all cases analysed by Igenomix, 90% of the people were carriers of at least one genetic mutation," says Dr. Rajni Khajuria from Igenomix.

For example, if both partners are carriers of Thalassemia and Thalassemia minor themselves, they can conceive a healthy baby through assisted reproductive technologies with the help of Igenomix's Preimplantation Genetic Diagnosis (PGD) test.

PGD screens the embryos for genetic mutation which both parents are a carrier for and enables them to select those embryos which are not affected by genetic disorder. It is indicated for couples with known personal or family history of monogenic disorders such as cystic fibrosis, fragile X syndrome, spinal muscular dystrophies (SMA), Duchenne muscular dystrophy (DMD), Huntington disease, Beta Thalassemia and many more. Even Fertile couples who have a known history of a genetic condition in their families can consider PGD testing.

About Igenomix 

Igenomix is a bio-technology company providing advanced services in reproductive genetics. Its consolidated experience and advanced research capabilities make it one of the world leaders in this field and guarantee the provision of effective solutions tailored to different infertility problems. It is present in Valencia (Spain), Miami, Los Angeles, New York, Mexico City, Sao Paulo, Dubai and Delhi, with a workforce of over 170 professionals.

For further information about the company, please visit or follow them on Facebook.

Media Contact: Divya Bhasin +91-(011)-6651-7800 Igenomix Marketing Dept. Igenomix


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store